These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 32138523)

  • 1. Assessing HIV provider knowledge, screening practices, and training needs for HIV-associated neurocognitive disorders. A short report.
    Gouse H; Masson CJ; Henry M; Marcotte TD; London L; Kew G; Rourke S; Robbins RN
    AIDS Care; 2021 Apr; 33(4):468-472. PubMed ID: 32138523
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Is the use of the QPC cognitive complaints questionnaire relevant for the screening strategy of HIV-Associated neurocognitive disorders?
    Zaegel-Faucher O; Laroche H; Tixier M; Morisseau V; Obry-Roguet V; Poizot-Martin I
    AIDS Care; 2021 Mar; 33(3):389-397. PubMed ID: 32279542
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevalence of HIV-associated neurocognitive disorder (HAND) in Turkey and assessment of Addenbrooke's Cognitive Examination Revised (ACE-R) test as a screening tool.
    Korten V; Ay U; Harı E; Tigen Tükenmez E; Gencer S; Akça Kalem S; Demirtaş Tatlıdede A; Gürvit İH
    HIV Med; 2021 Jan; 22(1):60-66. PubMed ID: 32964651
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Screening for HIV-Associated Neurocognitive Disorders: Sensitivity and Specificity.
    Robbins RN; Scott TM; Gouse H; Marcotte TD; Rourke SB
    Curr Top Behav Neurosci; 2021; 50():429-478. PubMed ID: 32677005
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Determining optimal impairment rating methodology for a new HIV-associated neurocognitive disorder screening procedure.
    Kamminga J; Bloch M; Vincent T; Carberry A; Brew BJ; Cysique LA
    J Clin Exp Neuropsychol; 2017 Oct; 39(8):753-767. PubMed ID: 28052738
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High prevalence of neurocognitive disorders observed among adult people living with HIV/AIDS in Southern Ethiopia: A cross-sectional study.
    Debalkie Animut M; Sorrie MB; Birhanu YW; Teshale MY
    PLoS One; 2019; 14(3):e0204636. PubMed ID: 30883557
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A Comparison of Five Brief Screening Tools for HIV-Associated Neurocognitive Disorders in the USA and South Africa.
    Joska JA; Witten J; Thomas KG; Robertson C; Casson-Crook M; Roosa H; Creighton J; Lyons J; McArthur J; Sacktor NC
    AIDS Behav; 2016 Aug; 20(8):1621-31. PubMed ID: 26860536
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diagnostic utility of the HIV dementia scale and the international HIV dementia scale in screening for HIV-associated neurocognitive disorders among Spanish-speaking adults.
    López E; Steiner AJ; Smith K; Thaler NS; Hardy DJ; Levine AJ; Al-Kharafi HT; Yamakawa C; Goodkin K
    Appl Neuropsychol Adult; 2017; 24(6):512-521. PubMed ID: 27712132
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Screening for HIV-Associated Neurocognitive Disorder (HAND) in Adults Aged 50 and Over Attending a Government HIV Clinic in Kilimanjaro, Tanzania. Comparison of the International HIV Dementia Scale (IHDS) and IDEA Six Item Dementia Screen.
    Kellett-Wright J; Flatt A; Eaton P; Urasa S; Howlett W; Dekker M; Kisoli A; Duijinmaijer A; Thornton J; McCartney J; Yarwood V; Irwin C; Mukaetova-Ladinska E; Akinyemi R; Lwezuala B; Gray WK; Walker RW; Dotchin CL; Makupa P; Paddick SM
    AIDS Behav; 2021 Feb; 25(2):542-553. PubMed ID: 32875460
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Validation of the International HIV Dementia Scale as a Screening Tool for HIV-Associated Neurocognitive Disorders in a German-Speaking HIV Outpatient Clinic.
    Marin-Webb V; Jessen H; Kopp U; Jessen AB; Hahn K
    PLoS One; 2016; 11(12):e0168225. PubMed ID: 27992497
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of Western Neuropsychological Test Battery in Detecting HIV-Associated Neurocognitive Disorders (HAND) in Zambia.
    Kabuba N; Anitha Menon J; Franklin DR; Heaton RK; Hestad KA
    AIDS Behav; 2017 Jun; 21(6):1717-1727. PubMed ID: 27278547
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Validity of the International HIV Dementia Scale in South Africa.
    Joska JA; Westgarth-Taylor J; Hoare J; Thomas KG; Paul R; Myer L; Stein DJ
    AIDS Patient Care STDS; 2011 Feb; 25(2):95-101. PubMed ID: 21214343
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevalence and 1-year incidence of HIV-associated neurocognitive disorder (HAND) in adults aged ≥50 years attending standard HIV clinical care in Kilimanjaro, Tanzania.
    Flatt A; Gentry T; Kellett-Wright J; Eaton P; Joseph M; Urasa S; Howlett W; Dekker M; Kisoli A; Rogathe J; Henderson L; Lewis T; Thornton J; McCartney J; Yarwood V; Irwin C; Mukaetova-Ladinska EB; Akinyemi R; Gray WK; Walker RW; Dotchin CL; Quaker AS; Makupa PC; Paddick SM
    Int Psychogeriatr; 2023 Jul; 35(7):339-350. PubMed ID: 33757616
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development of a neurocognitive test battery for HIV-associated neurocognitive disorder (HAND) screening: suggested solutions for resource-limited clinical settings.
    Chan LG; Ho MJ; Lin YC; Ong Y; Wong CS
    AIDS Res Ther; 2019 Apr; 16(1):9. PubMed ID: 30987670
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Screening for HIV-associated dementia in South Africa: potentials and pitfalls of task-shifting.
    Robbins RN; Remien RH; Mellins CA; Joska JA; Stein DJ
    AIDS Patient Care STDS; 2011 Oct; 25(10):587-93. PubMed ID: 21919734
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Screening for HIV-associated neurocognitive disorders in perinatally infected adolescents: youth-International HIV Dementia Scale validation.
    Phillips NJ; Thomas KGF; Myer L; Sacktor N; Zar HJ; Stein DJ; Hoare J
    AIDS; 2019 Apr; 33(5):815-824. PubMed ID: 30649059
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reliability of the lay adherence counsellor administered substance abuse and mental illness symptoms screener (SAMISS) and the International HIV Dementia Scale (IHDS) in a primary care HIV clinic in Cape Town, South Africa.
    Breuer E; Stoloff K; Myer L; Seedat S; Stein DJ; Joska J
    AIDS Behav; 2012 Aug; 16(6):1464-71. PubMed ID: 22001934
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of brief screening tools for neurocognitive impairment in HIV/AIDS: a systematic review of the literature.
    Zipursky AR; Gogolishvili D; Rueda S; Brunetta J; Carvalhal A; McCombe JA; Gill MJ; Rachlis A; Rosenes R; Arbess G; Marcotte T; Rourke SB
    AIDS; 2013 Sep; 27(15):2385-401. PubMed ID: 23751261
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HIV-associated neurocognitive disorder in HIV-infected Koreans: the Korean NeuroAIDS Project.
    Ku NS; Lee Y; Ahn JY; Song JE; Kim MH; Kim SB; Jeong SJ; Hong KW; Kim E; Han SH; Song JY; Cheong HJ; Song YG; Kim WJ; Kim JM; Smith DM; Choi JY
    HIV Med; 2014 Sep; 15(8):470-7. PubMed ID: 24580888
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neuropsychological tests associated with symptomatic HIV-associated neurocognitive disorder (HAND) in a cohort of older adults in Tanzania.
    Fotheringham L; Lawson RA; Urasa S; Boshe J; Mukaetova-Ladinska EB; Rogathi J; Howlett W; Dekker MCJ; Gray WK; Evans J; Walker RW; Makupa PC; Paddick SM
    J Int Neuropsychol Soc; 2024 Aug; 30(7):660-670. PubMed ID: 38766814
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.